1. de Almeida, Bruna O, de Almeida, Larissa C, Costa-Lotufo, Leticia V, Machado-Neto, João A. 2022. ANKHD1 contributes to the malignant phenotype of triple-negative breast cancer cells. In Cell biology international, 46, 1433-1446. doi:10.1002/cbin.11844. https://pubmed.ncbi.nlm.nih.gov/35842770/
2. Machado-Neto, João Agostinho, Lazarini, Mariana, Favaro, Patricia, Olalla Saad, Sara Teresinha, Traina, Fabiola. 2014. ANKHD1 silencing inhibits Stathmin 1 activity, cell proliferation and migration of leukemia cells. In Biochimica et biophysica acta, 1853, 583-93. doi:10.1016/j.bbamcr.2014.12.012. https://pubmed.ncbi.nlm.nih.gov/25523139/
3. Yao, Ping'an, Li, Yecheng, Shen, Wenqi, Cao, Jianping, Xing, Chungen. 2018. ANKHD1 silencing suppresses the proliferation, migration and invasion of CRC cells by inhibiting YAP1-induced activation of EMT. In American journal of cancer research, 8, 2311-2324. doi:. https://pubmed.ncbi.nlm.nih.gov/30555746/
4. Machado-Neto, João Agostinho, Lazarini, Mariana, Favaro, Patricia, Saad, Sara Teresinha Olalla, Traina, Fabiola. 2014. ANKHD1, a novel component of the Hippo signaling pathway, promotes YAP1 activation and cell cycle progression in prostate cancer cells. In Experimental cell research, 324, 137-45. doi:10.1016/j.yexcr.2014.04.004. https://pubmed.ncbi.nlm.nih.gov/24726915/
智鼠故事 
